PL3949952T3 - Kompozycja farmaceutyczna - Google Patents
Kompozycja farmaceutycznaInfo
- Publication number
- PL3949952T3 PL3949952T3 PL20784888.8T PL20784888T PL3949952T3 PL 3949952 T3 PL3949952 T3 PL 3949952T3 PL 20784888 T PL20784888 T PL 20784888T PL 3949952 T3 PL3949952 T3 PL 3949952T3
- Authority
- PL
- Poland
- Prior art keywords
- pharmaceutical composition
- pharmaceutical
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2019070997 | 2019-04-03 | ||
PCT/JP2020/015225 WO2020204142A1 (ja) | 2019-04-03 | 2020-04-02 | 医薬組成物 |
Publications (1)
Publication Number | Publication Date |
---|---|
PL3949952T3 true PL3949952T3 (pl) | 2024-10-14 |
Family
ID=72668177
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL20784888.8T PL3949952T3 (pl) | 2019-04-03 | 2020-04-02 | Kompozycja farmaceutyczna |
Country Status (15)
Country | Link |
---|---|
US (1) | US12178814B2 (pl) |
EP (1) | EP3949952B1 (pl) |
JP (1) | JP6822619B1 (pl) |
KR (1) | KR20210148252A (pl) |
CN (1) | CN113677330B (pl) |
CA (1) | CA3131461C (pl) |
ES (1) | ES2993145T3 (pl) |
MX (1) | MX2021012033A (pl) |
MY (1) | MY204603A (pl) |
PH (1) | PH12021552500A1 (pl) |
PL (1) | PL3949952T3 (pl) |
PT (1) | PT3949952T (pl) |
SG (1) | SG11202110315SA (pl) |
TW (1) | TWI836051B (pl) |
WO (1) | WO2020204142A1 (pl) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW202340177A (zh) | 2021-12-30 | 2023-10-16 | 美商拜歐米富士恩股份有限公司 | 作為 flt3抑制劑之吡嗪化合物 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1923074A4 (en) * | 2005-08-10 | 2011-09-14 | Shionogi & Co | TABLET WHICH CAN BE ORALLY DISINTEGRATED |
WO2008119033A1 (en) * | 2007-03-27 | 2008-10-02 | Eurand, Inc. | Pharmaceutical compositions comprising an active substance from the substituted benzhydrylpiperazine family |
JP5399749B2 (ja) | 2008-03-27 | 2014-01-29 | 沢井製薬株式会社 | プロトンポンプ阻害剤を含有する被覆微粒子 |
JP5296456B2 (ja) * | 2008-08-26 | 2013-09-25 | 大日本住友製薬株式会社 | 溶出が良好なイルベサルタン含有医薬組成物および口腔内崩壊錠 |
CA2760061C (en) | 2009-05-08 | 2017-02-28 | Astellas Pharma Inc. | Diamino heterocyclic carboxamide compound |
DE102010024866A1 (de) | 2010-06-24 | 2011-12-29 | Pharmatech Gmbh | Formulierung zur Geschmacksmaskierung |
IT1406107B1 (it) * | 2010-12-13 | 2014-02-14 | Alfa Wassermann Spa | Composizioni solide comprendenti antiinfiammatori non steroidei, processi per la loro preparazione e loro uso. |
EP2674149B1 (en) * | 2012-06-15 | 2017-10-04 | Shin-Etsu Chemical Co., Ltd. | Method of preparing composite granule comprising low-substituted hydroxypropyl cellulose and rapid release preparation |
US20150141517A1 (en) | 2013-11-15 | 2015-05-21 | Shin-Etsu Chemical Co., Ltd. | Granulated composite, rapid release tablet and method for producing same |
CA2940920C (en) | 2014-03-27 | 2023-08-29 | Ucb Biopharma Sprl | Pharmaceutical compositions comprising levocetirizine |
JP6549428B2 (ja) * | 2014-07-23 | 2019-07-24 | エスエス製薬株式会社 | 経口組成物 |
PT3280447T (pt) | 2015-04-08 | 2019-05-14 | Torrent Pharmaceuticals Ltd | Formulações farmacêuticas |
MX378947B (es) | 2015-07-03 | 2025-03-11 | Astellas Pharma Inc | Composición farmacéutica estable para administración oral. |
TWI623316B (zh) * | 2015-12-22 | 2018-05-11 | Taiho Pharmaceutical Co Ltd | Antitumor effect enhancer derived from pyrrolopyrimidine compound |
WO2017170348A1 (en) | 2016-03-29 | 2017-10-05 | Astellas Pharma Inc. | Combination therapy for the treatment of acute myeloid leukemia |
JP6778051B2 (ja) * | 2016-08-18 | 2020-10-28 | 沢井製薬株式会社 | オセルタミビルリン酸塩含有医薬組成物 |
-
2020
- 2020-04-02 CN CN202080026179.1A patent/CN113677330B/zh active Active
- 2020-04-02 EP EP20784888.8A patent/EP3949952B1/en active Active
- 2020-04-02 KR KR1020217035396A patent/KR20210148252A/ko active Pending
- 2020-04-02 MX MX2021012033A patent/MX2021012033A/es unknown
- 2020-04-02 WO PCT/JP2020/015225 patent/WO2020204142A1/ja unknown
- 2020-04-02 MY MYPI2021005901A patent/MY204603A/en unknown
- 2020-04-02 ES ES20784888T patent/ES2993145T3/es active Active
- 2020-04-02 SG SG11202110315SA patent/SG11202110315SA/en unknown
- 2020-04-02 JP JP2020545744A patent/JP6822619B1/ja active Active
- 2020-04-02 PT PT207848888T patent/PT3949952T/pt unknown
- 2020-04-02 PL PL20784888.8T patent/PL3949952T3/pl unknown
- 2020-04-02 CA CA3131461A patent/CA3131461C/en active Active
- 2020-04-02 PH PH1/2021/552500A patent/PH12021552500A1/en unknown
- 2020-04-02 US US17/441,361 patent/US12178814B2/en active Active
- 2020-04-06 TW TW109111460A patent/TWI836051B/zh active
Also Published As
Publication number | Publication date |
---|---|
CN113677330B (zh) | 2023-10-31 |
CA3131461A1 (en) | 2020-10-08 |
EP3949952B1 (en) | 2024-07-17 |
PT3949952T (pt) | 2024-09-13 |
ES2993145T3 (en) | 2024-12-23 |
JPWO2020204142A1 (ja) | 2021-04-30 |
TWI836051B (zh) | 2024-03-21 |
CA3131461C (en) | 2024-06-25 |
CN113677330A (zh) | 2021-11-19 |
MX2021012033A (es) | 2021-11-03 |
SG11202110315SA (en) | 2021-10-28 |
PH12021552500A1 (en) | 2022-10-17 |
MY204603A (en) | 2024-09-05 |
US20220152020A1 (en) | 2022-05-19 |
TW202103702A (zh) | 2021-02-01 |
EP3949952A4 (en) | 2022-12-21 |
EP3949952A1 (en) | 2022-02-09 |
JP6822619B1 (ja) | 2021-01-27 |
WO2020204142A1 (ja) | 2020-10-08 |
KR20210148252A (ko) | 2021-12-07 |
US12178814B2 (en) | 2024-12-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB201911928D0 (en) | Pharmaceutical compounds | |
GB201911517D0 (en) | Pharmaceutical composition | |
GB202008961D0 (en) | Pharmaceutical composition | |
IL276888A (en) | Pharmaceutical compositions containing timolol | |
GB201911944D0 (en) | Pharmaceutical compounds | |
GB201804548D0 (en) | Pharmaceutical compositions | |
IL290469A (en) | Oral pharmaceutical preparation | |
GB201914910D0 (en) | Pharmaceutical compounds | |
GB201807053D0 (en) | Pharmaceutical composition | |
IL291570A (en) | Pharmaceutical preparations | |
GB201808571D0 (en) | Pharmaceutical compositions | |
SG11202103374TA (en) | Pharmaceutical composition | |
GB201915932D0 (en) | Pharmaceutical compounds | |
GB201915273D0 (en) | Pharmaceutical compounds | |
GB201901989D0 (en) | Pharmaceutical combinations | |
GB201808567D0 (en) | Pharmaceutical compositions | |
IL285728A (en) | Pharmaceutical composition | |
SG11202110315SA (en) | Pharmaceutical composition | |
SMT202400011T1 (it) | Composizione farmaceutica | |
GB201912686D0 (en) | Pharmaceutical composition | |
GB201908003D0 (en) | Pharmaceutical composition | |
ZA202006541B (en) | Pharmaceutical composition comprising brexpiprazole | |
GB201820689D0 (en) | Pharmaceutical composition | |
GB201904783D0 (en) | New pharmaceutical compositions | |
GB201904767D0 (en) | New pharmaceutical compositions |